Xtant Medical

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Xtant Medical sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).

3 total trials 2 currently recruiting 1 completed upper quartile by trial count

Xtant Medical: 3 sponsored US clinical trials, 2 recruiting.

Xtant Medical sponsors 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 1 completed. The most-studied condition in this pipeline is Spinal Stenosis Lumbar, with 1 trials.

Upper-quartile sponsor footprint

Xtant Medical sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

3 total, page 1 of 1

RECRUITING

Prospective SPINE Registry

NCT04176562
RECRUITING NA

Coflex PS3 Actual Conditions for Use Study

NCT02555280
COMPLETED

Clinical Evaluation of Fortilink® TETRAfuse® Interbody Fusion Device in Subjects With Degenerative Disc Disease

NCT03761563

Therapeutic Areas

Spinal Stenosis Lumbar 1
Fusion of Joint 1
Sacroiliac 1
Spinal Instability 1
Sacroiliac; Fusion 1
Fusion of Spine 1
Spinal Disease 1
Joint Diseases 1
Spinal Fusion 1
Musculoskeletal Diseases 1

What is open in the Xtant Medical pipeline

2 recruiting of 3 indexed (67% open); 1 completed (33%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Spinal Stenosis Lumbar (1 trial), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Xtant Medical: open-pipeline peers nationwide

Peers matched on 3 registered trials and 67% open enrollment, not the therapeutic-area sidebar.

Xtant Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 234567 0%20%40%60%80% Total trials Recruiting share Xtant Medical10xBio22nd Century GroupAA SecordAAADRS Clinical Research CenterAbbisko Therapeutics CoABL BioAccelerated Cure Project for Multiple SclerosisAdvanced Reconstructive Surgery Alliance
Xtant Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Xtant Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 3 trials (± recruiting share)

Sponsors near 67% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Xtant Medical page

3 registered trials is a research-attention snapshot, not an endorsement of Xtant Medical or any single study.

  • 2 of Xtant Medical's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Spinal Stenosis Lumbar is the condition Xtant Medical studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Spinal Stenosis Lumbar trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Xtant Medical pipeline card: 3 registered trials from official public datasets.Report a data error.